Metvix 160 mg/g cream
Authorisation PA25691/008/001 · Galderma S.A. the Netherlands Branch
- Licence holder
- Galderma S.A. the Netherlands Branch (all products →)
- Active substance
- METHYL AMINOLEVULINATE HYDROCHLORIDE
- Dosage form
- Cream
- Route of administration
- Topical use
- ATC codes
- L01XD, L01XD03
- First authorised
- 22/03/2002
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
METHYL AMINOLEVULINATE HYDROCHLORIDE: supply and approvals
1 authorised product on the HPRA list contains METHYL AMINOLEVULINATE HYDROCHLORIDE. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 15 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 15 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 16 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 24 years (since 22 March 2002). The HPRA list marks it as marketed in Ireland.
Other medicines with METHYL AMINOLEVULINATE HYDROCHLORIDE in Ireland
No other product on the HPRA list contains METHYL AMINOLEVULINATE HYDROCHLORIDE.
Other substances in ATC group L01XD
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 2 other active substances share the group L01XD with this product:
5-aminolevulinic acid hydrochloride (3) · Padeliporfin (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Galderma S.A. the Netherlands Branch holds 7 products on the HPRA list, with 8 different active substances; 4 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.